Meglumine Diatrizoate TCI M3592

Meglumine Diatrizoate is a chemical compound widely used in laboratory experiments, particularly in analytical chemistry and medical research. It is a key component in radiographic contrast agents, enhancing the visibility of internal body structures during medical imaging. As a fundamental building block in the synthesis of complex compounds, it plays a crucial role in the development of new substances with clinical and pharmacological applications. Its chemical stability and solubility in organic solvents make it a versatile material for various chemical reactions, both in acidic and basic conditions.

The compound's chemical stability and solubility in organic solvents are key factors that make it a preferred choice for laboratory use. It is not easily degraded, ensuring long-term storage and reliable experimental results. Its ability to remain stable under different chemical conditions enhances its usability in a wide range of applications. These properties make it an essential material for researchers working in both pharmaceutical and chemical fields.

In Indonesian laboratories, Meglumine Diatrizoate is commonly used in radiography studies, chemical compound analysis, and drug development. Its role as a contrast agent and building block makes it a vital component in various research projects. It is frequently utilized in academic and industrial settings to support scientific investigations and innovation in the pharmaceutical and medical sectors.

• Radiographic Imaging: Used in contrast agents to enhance visibility of internal structures during X-ray and CT scans, aiding in accurate diagnosis.
• Pharmaceutical Research: Serves as a building block for synthesizing new compounds with potential therapeutic applications in medicine.
• Chemical Analysis: Applied in analytical chemistry for testing and characterizing complex chemical structures and reactions.
• Medical Diagnostics: Utilized in diagnostic imaging to improve the clarity and detail of medical images, supporting clinical assessments.
• Drug Development: Incorporated into formulations for developing new drugs, particularly those requiring contrast properties or chemical stability.

Meglumine Diatrizoate should be stored in a cool, dry place, away from direct sunlight and moisture. It is recommended to keep the compound in a sealed container to prevent contamination and maintain its chemical integrity. Due to its chemical stability, it does not require refrigeration but should be protected from extreme temperatures. In laboratory settings, it is important to handle the compound with appropriate personal protective equipment to ensure safety. Proper labeling and storage conditions help maintain its effectiveness and usability in research applications.

—